Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Altucci

Showing results (221-230 of 358) with videos related to

Pageof 36
Sort By:
Cardiovascular Diabetology|July 24, 2021
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicinVincenzo Quagliariello, Michelino De Laurentiis, Domenica Rea, et al.
Biomed Research International|September 23, 2014
SIRT1 inhibition affects angiogenic properties of human MSCsChiara Botti, Botti Chiara, Ilaria Caiafa, et al.
Frontiers in Oncology|February 15, 2021
Searching for a Putative Mechanism of RIZ2 Tumor-Promoting Function in Cancer ModelsMonica Rienzo, Anna Sorrentino, Erika Di Zazzo, et al.
Frontiers in Oncology|January 7, 2022
MRI Radiomics in Prostate Cancer: A Reliability StudyFabrizio Urraro, Valerio Nardone, Alfonso Reginelli, et al.
Chemmedchem|February 8, 2014
Quinoline-based p300 histone acetyltransferase inhibitors with pro-apoptotic activity in human leukemia U937 cellsAlessia Lenoci, Stefano Tomassi, Mariarosaria Conte, et al.
Chemmedchem|October 25, 2013
Carprofen analogues as sirtuin inhibitors: enzyme and cellular studiesPaolo Mellini, Vincenzo Carafa, Barbara Di Rienzo, et al.
Molecular Pharmacology|August 2, 2007
Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemiaAntonello Mai, Katija Jelicic, Dante Rotili, et al.
Journal of Medicinal Chemistry|June 28, 2014
1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cellsSergio Valente, Daniela Trisciuoglio, Teresa De Luca, et al.
Journal of Molecular Endocrinology|July 20, 2010
HDACs class II-selective inhibition alters nuclear receptor-dependent differentiationAngela Nebbioso, Carmela Dell'Aversana, Anne Bugge, et al.
Plos One|December 19, 2013
HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or bIlaria Lepore, Carmela Dell'Aversana, Maxim Pilyugin, et al.
Pageof 36

Showing results (221-230 of 358) with videos related to

Sort By:
Pageof 36
Cardiovascular Diabetology|July 24, 2021
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicinVincenzo Quagliariello, Michelino De Laurentiis, Domenica Rea, et al.
Biomed Research International|September 23, 2014
SIRT1 inhibition affects angiogenic properties of human MSCsChiara Botti, Botti Chiara, Ilaria Caiafa, et al.
Frontiers in Oncology|February 15, 2021
Searching for a Putative Mechanism of RIZ2 Tumor-Promoting Function in Cancer ModelsMonica Rienzo, Anna Sorrentino, Erika Di Zazzo, et al.
Frontiers in Oncology|January 7, 2022
MRI Radiomics in Prostate Cancer: A Reliability StudyFabrizio Urraro, Valerio Nardone, Alfonso Reginelli, et al.
Chemmedchem|February 8, 2014
Quinoline-based p300 histone acetyltransferase inhibitors with pro-apoptotic activity in human leukemia U937 cellsAlessia Lenoci, Stefano Tomassi, Mariarosaria Conte, et al.
Chemmedchem|October 25, 2013
Carprofen analogues as sirtuin inhibitors: enzyme and cellular studiesPaolo Mellini, Vincenzo Carafa, Barbara Di Rienzo, et al.
Molecular Pharmacology|August 2, 2007
Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemiaAntonello Mai, Katija Jelicic, Dante Rotili, et al.
Journal of Medicinal Chemistry|June 28, 2014
1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cellsSergio Valente, Daniela Trisciuoglio, Teresa De Luca, et al.
Journal of Molecular Endocrinology|July 20, 2010
HDACs class II-selective inhibition alters nuclear receptor-dependent differentiationAngela Nebbioso, Carmela Dell'Aversana, Anne Bugge, et al.
Plos One|December 19, 2013
HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or bIlaria Lepore, Carmela Dell'Aversana, Maxim Pilyugin, et al.
Pageof 36